Jena-based organ-on-chip specialist Dynamic42 has inked a strategic partnership with Ohio Lumex Co., Inc. The Ohio-based company, which is an established provider of life science and analytics solutions, will exclusively distribute Dynamic42’s human 3D-sphaeroid-based organ-on-chip models in the U.S. and Canadian markets.
ADVERTISEMENT
Just three weeks to go until Europe’s largest event for laboratory automation and drug screening. SLAS Europe 2025, organised by the Society for Laboratory Automation and Screening (SLAS), will take place from 20-22 May in Hamburg, Germany. In a series, European Biotechnology presents the 12 most innovative SMEs. Today: Nanoworx BV.
Only three weeks to go until Europe’s largest event for laboratory automation and drug screening. SLAS Europe 2025, organised by the Society for Laboratory Automation and Screening (SLAS), will take place in Hamburg from 20-22 May. In a series, European Biotechnology Magazine presents the 12 most innovative SMEs today: UK-based Nanovery Ltd
NovoArc GmbH, an Austrian biotech startup and BIOTECH AUSTRIA member, develops lipid-based formulations to enable the oral delivery of drugs that currently require injection. Its innovative approach paves the way for more convenient and effective treatments.
The Society for Laboratory Automation and Screening (SLAS) has selected 12 start-ups to exhibit at Europe’s premier automation conference as part of its Innovation AveNew programme at SLAS Europe 2025, which takes place from 20-22 May in Hamburg, Germany.
Join YEBN’s top biotech event in Budapest! Connect with innovators, learn from professionals, and shape the future of biotech. Don’t miss this opportunity to network and grow, join us now!
The BIOTECH AUSTRIA hybrid annual meeting took place on 25 February 2025 in Vienna, 2025 being the fifth anniversary.
SLAS is pleased to bring together the laboratory automation and life sciences research communities at the SLAS Europe 2025 Conference & Exhibition at the Congress Center Hamburg, 20-22 May.
Roche researchers have introduced a greatly improved long-read nanopore sequencing method that has the potential to erase the sequencing-by-synthesis approach of market leader Illumina.
This year’s US$10,000 Innovation Award for the most relevant automation technology presentation at SLAS 2025 goes to Taci Pereira, CEO of Systemic Bio from Houston. She prevailed against nine finalists at the important automation conference SLAS 2025 in San Diego.